65 I B, drugs, pharmaceuticals,&hematology related products, FSS contract award
Active Awarded Last action
- Contract number
- 36F79720D0099
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 215
Award facts
- Opportunity
-
- M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment Pre-Solicitation · M5Q50A03R8 · Posted Jun 21, 2018
- Last date to order 95% complete
- IDV ceiling
- $396,000,000.00
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
The General Services Administration issued a Federal Supply Schedule contract to Otsuka America Pharmaceutical Inc. on March 15, 2020, under the Pharmaceuticals and Drugs schedule (FSS-61-IB) with a ceiling value of $396 million and an ultimate completion date of March 14, 2027. This is a multi-agency catalog-based vehicle through which federal agencies, including the Department of Veterans Affairs, place delivery orders against Otsuka's established price list rather than conducting individual competitions.
Otsuka America Pharmaceutical Inc., headquartered in Rockville, Maryland, holds approval under the Drugs, Pharmaceuticals & Hematology Related Products category on this schedule. The contract carries no set-aside designation, reflecting the contractor's status as a large pharmaceutical manufacturer. Place of performance spans multiple VA locations nationwide, including Pittsburgh, Pennsylvania; Belle Isle, Florida; Potomac, Maryland; Rockville, Maryland; and North Las Vegas, Nevada.
Ordering activity under this FSS contract has been substantial and ongoing. The source documents a single award Blanket Purchase Agreement valued at $83.3 million (awarded March 27, 2025, with completion March 26, 2027) for Jynarque (tolvaptan) with an additional product line for Voyxact, as well as an earlier $15 million BPA (awarded March 27, 2020, completing March 26, 2025) also for Jynarque with 2025 public law pricing updates. Delivery orders issued under this Schedule against the BPA framework span from January 2024 through September 2025, with individual order values ranging from $12,559.90 to $637,703.39. Orders originate from multiple Veterans Integrated Service Networks (VISN 5, VISN 20, VISN 21) and support procurement of Jynarque in various dosage formulations (90mg/30mg, 45mg/15mg, and bulk configurations) for treatment of autosomal dominant polycystic kidney disease and hyponatremia. Larger orders—including $637,703.39 (October 2024), $151,031.04 (June 2024), $125,848.80 (February 2024), and $100,645.76 (January 2024)—reflect seasonal or emergency pharmaceutical procurement needs across the VA system. The contractor supplies specialty pharmaceuticals to the Veterans Health Administration through streamlined ordering procedures under the Schedule, enabling rapid access to complex medications across VA healthcare networks.
Task orders
Show 40 more
Latest 50 of 215 listed here. See the rest on GovTribe.
IDV awards
| IDV | Agency | Ceiling | Awarded |
|---|---|---|---|
| 36E79725A0011 | National Acquisition Center (VA) | $83,342,090 | |
| 36E79720A0007 | National Acquisition Center (VA) | $15,000,000 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 44
Quick answers
Who was awarded contract 36F79720D0099?
36F79720D0099 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on March 15, 2020.
How much is contract 36F79720D0099 worth?
36F79720D0099's own ceiling is $396,000,000.
How many orders have been placed under contract 36F79720D0099?
215 orders have been placed under 36F79720D0099, the latest on July 30, 2026.
Who can order from contract 36F79720D0099?
36F79720D0099 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79720D0099 part of a contract vehicle?
Yes. 36F79720D0099 is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36F79720D0099 competed?
The extent of competition for 36F79720D0099 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV